Related Experiment Video
Updated: Jan 30, 2026

Large Scale Zebrafish-Based In vivo Small Molecule Screen
Published on: December 30, 2010
Structure-Based Virtual Screening Identifies TREM2-Targeted Small Molecules that Enhance Microglial Phagocytosis
Sungwoo Cho1, Baljit Kaur1, Kevin Lam2
1Department of Radiology, Molecular Imaging Innovations Institute (MI3), Weill Cornell Medicine, New York, New York, USA.
Abstract:
Triggering receptor expressed on myeloid cells 2 (TREM2) is a microglia-specific receptor whose activation promotes phagocytosis and neuroprotection in Alzheimer's disease (AD) and related neurodegenerative disorders. While therapeutic efforts have largely focused on antibodies, small-molecule TREM2 modulators remain limited. Here, we applied a structure-based virtual screening workflow targeting a putative allosteric site on TREM2, guided by PyRod-derived pharmacophores from molecular dynamics simulations. Screening of the Enamine Collection (ESC) yielded 20 candidate compounds, three of which demonstrated binding in TRIC assays. The top hit, EN020, exhibited a KD of 14.2 µM (MST) and 35.9 µM (SPR), and significantly enhanced microglial phagocytosis in BV2 cells, outperforming the known TREM2 agonist VG-3927. A preliminary structure-activity relationship (SAR) study, including synthetic and catalog-derived analogs, highlighted a narrow tolerance for scaffold modifications, with only T2V002 retaining partial TREM2 binding affinity. This work identifies EN020 as a novel small-molecule TREM2 modulator with functional activity, providing a framework for rational optimization toward potential AD therapeutics.
Insights
Researchers identified EN020, a novel small-molecule modulator of Triggering Receptor expressed on myeloid cells 2 (TREM2). This compound enhances microglial phagocytosis, offering a new therapeutic avenue for Alzheimer's disease (AD).
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Triggering receptor expressed on myeloid cells 2 (TREM2) is crucial for microglial function and neuroprotection in Alzheimer's disease (AD).
- Existing therapeutic strategies for TREM2 primarily involve antibodies, with limited development of small-molecule modulators.
Purpose of the Study:
- To identify novel small-molecule modulators of TREM2 using a structure-based virtual screening approach.
- To evaluate the functional activity of identified compounds in enhancing microglial phagocytosis.
Main Methods:
- Employed a structure-based virtual screening workflow targeting a putative allosteric site on TREM2.
- Utilized PyRod-derived pharmacophores from molecular dynamics simulations for virtual screening.
- Screened the Enamine Collection (ESC) and validated hits using TRIC assays, MST, and SPR.
Main Results:
- Identified EN020 as a top-hit small-molecule TREM2 modulator with demonstrated binding affinity (KD of 14.2 µM via MST).
- EN020 significantly enhanced microglial phagocytosis in BV2 cells, surpassing the efficacy of the known agonist VG-3927.
- Preliminary structure-activity relationship (SAR) studies indicated limited tolerance for scaffold modifications, with T2V002 retaining partial binding.
Conclusions:
- EN020 represents a novel, functionally active small-molecule TREM2 modulator.
- This discovery provides a promising lead compound and a framework for developing new therapeutics for AD and related neurodegenerative disorders.
Related Concept Videos
Phagocytosis
Phagocytosis
The objective of phagocytosis is often destruction. Cells use phagocytosis to eliminate unwelcome visitors, like pathogens (e.g., viruses and bacteria). Many immune system cells,...
Virtual Work
In static equilibrium, a body can experience an imaginary or virtual movement, such as displacement or rotation. The virtual work done by a force is equal to the dot product of force and virtual displacement in the direction of the force. When it comes to virtually rotating a...
Self-Evaluation: Self-Enhancement and Self-Verification
Molecules and Compounds
Principle of Virtual Work: Problem Solving
To apply the principle of virtual work,...

